[PDF][PDF] Citicoline: pharmacological and clinical review, 2010 update

JJ Secades - Rev Neurol, 2011 - researchgate.net
This review is based on the previous one published in 2010–Secades JJ. Citicoline:
pharmacological and clinical review, 2010 update. Rev Neurol 2011; 52 (Suppl 2): S1-62 …

[PDF][PDF] Citicoline: pharmacological and clinical review, 2016 update

JJ Secades - Rev Neurol, 2016 - article.imrpress.com
This review is based on the previous one published in 2010–Secades JJ. Citicoline:
pharmacological and clinical review, 2010 update. Rev Neurol 2011; 52 (Suppl 2): S1-62 …

Tacrine–hydrogen sulfide donor hybrid ameliorates cognitive impairment in the aluminum chloride mouse model of Alzheimer's disease

X Cheng, J Gu, Y Pang, J Liu, T Xu, X Li… - ACS Chemical …, 2019 - ACS Publications
Alzheimer's disease (AD) is a neurodegenerative disorder, characterized by progressive
loss of memory and cognitive function, and is associated with the deficiency of synaptic …

Telmisartan protects against aluminum-induced Alzheimer-like pathological changes in rats

M Khalifa, MM Safar, RM Abdelsalam, HF Zaki - Neurotoxicity research, 2020 - Springer
Currently, there is no effective mean for treatment or prevention of Alzheimer's disease (AD).
Commonly used AD drugs have a moderate effect and treat only the associated symptoms …

Intranasal niosomal in situ gel as a novel strategy for improving citicoline efficacy and brain delivery in treatment of epilepsy: in vitro and ex vivo characterization and in …

MA Bekhet, AA Ali, RM Kharshoum, FIA El-Ela… - Journal of …, 2022 - Elsevier
The high hydrophilicity of citicoline and its rapid metabolism are the two main obstacles
hindering intact molecules from passing the blood-brain barrier. This study aimed to …

[HTML][HTML] Brain targeting of citicoline sodium via hyaluronic acid-decorated novel nano-transbilosomes for mitigation of Alzheimer's disease in a rat model: formulation …

KM AbouElhassan, HA Sarhan… - International Journal …, 2022 - ncbi.nlm.nih.gov
Background Alzheimer's disease (AD) is one of the furthermost advanced
neurodegenerative disorders resulting in cognitive and behavioral impairment. Citicoline …

[PDF][PDF] Citicoline in the treatment of cognitive impairment

JJ Secades - J Neurol Exp Neurosci, 2019 - jneuroscience.com
Vascular cognitive impairment is a process which is more frequent in patients with
cardiovascular risk factors. The etiology of this kind of impairment could be related to …

[HTML][HTML] Past and current drug repurposing clinical trials to treat cognition in methamphetamine use: a scoping review of pharmacotherapy candidates

MMS Peters, CHJ Park, A Turner, AA Guerin… - Addiction …, 2023 - Elsevier
Globally, methamphetamine is one of the most widely used illicit substances. Despite this,
there are no Food and Drug Administration (FDA)-approved pharmacotherapies for treating …

[HTML][HTML] Protective effects of citicoline and benfotiamine each alone and in combination on streptozotocin-induced memory impairment in mice

M Safavi, A Hosseini-Sharifabad… - Clinical …, 2020 - ncbi.nlm.nih.gov
Objective Diabetes mellitus is associated with cognitive disorders such as Alzheimer's
disease. Studies have shown that citicoline and benfotiamine can improve memory and …

[HTML][HTML] Magnesium increases the protective effect of citicoline on aluminum chloride-induced cognitive impairment

A Hosseini-Sharifabad, M Rabbani… - Clinical …, 2020 - ncbi.nlm.nih.gov
Objective Alzheimer's disease is a popular neurodegenerative disorder which is growing in
the elderly people. Exposure to environmental pollutant like aluminum could trigger or …